Description

9-[3-(p-Chlorobenzoyl)Propyl]-1-Oxa-3,9-Diazaspiro[5.5]Undecan-2-One is a sophisticated heterocyclic organic compound featuring a spirocyclic and benzoyl moiety. This complex structure makes it a valuable advanced pharmaceutical intermediate and a key building block in medicinal chemistry research. It is primarily sought by R&D and production teams in the pharmaceutical and fine chemical sectors for the synthesis of novel active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug molecules, particularly those targeting neurological or receptor-based pathways.
• Medicinal Chemistry Research: Serves as a versatile scaffold for constructing compound libraries in drug discovery programs aimed at identifying new therapeutic candidates.
• API Synthesis: Used in the development and scale-up production of Active Pharmaceutical Ingredients (APIs) requiring its specific spirocyclic architecture.
• Biochemical Tool Compound: Potential use in pharmacological studies as a ligand or probe to investigate specific biological targets and mechanisms.
• Fine Chemical Production: Employed in the custom synthesis of high-value, specialty chemicals for advanced material science applications.

Basic Information

Item	Detail
Product Name	9-[3-(p-Chlorobenzoyl)Propyl]-1-Oxa-3,9-Diazaspiro[5.5]Undecan-2-One
CAS No.	54981-19-0
Molecular Formula	C21H29ClN2O3
Molecular Weight	392.92 g/mol
Synonyms	1-Oxa-3,9-diazaspiro[5.5]undecan-2-one, 9-[3-(4-chlorobenzoyl)propyl]-; 9-[3-(4-Chlorobenzoyl)propyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one; 54981-19-0; p-Chlorobenzoylpropyl oxadiazaspiro compound; Spirocyclic benzamide derivative; 3,9-Diazaspiro[5.5]undecane intermediate
EINECS	Contact for details

Quality Control

We maintain a strict quality management system to ensure batch-to-batch consistency and high purity. Our products undergo rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment. Our manufacturing and quality processes are designed to support cGMP compliance for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.